On the basis of the ‘binding–sorting’ model derived from the molecular roles of HIP1R, we have rationally designed the peptide PD-LYSO, incorporating the lysosome-sorting signal and the PD-L1-binding sequence of HIP1R, and used it to successfully deplete PD-L1 expression in tumor cells129. This evidence concerns the gene HIP1R and neoplasm.